Cardiac 7-transmembrane-spanning domain receptor portfolios: Diversify, diversify, diversify

Journal of Clinical Investigation

Volumn 116, Issue 4, 2006, Pages 875-877

  Liggett, Stephen B ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 1 ADRENERGIC RECEPTOR; ALPHA 2 ADRENERGIC RECEPTOR; ANGIOTENSIN RECEPTOR; GUANINE NUCLEOTIDE BINDING PROTEIN; MEMBRANE PROTEIN; PROTEIN 7 TM; RECEPTOR PROTEIN; UNCLASSIFIED DRUG;

HEART FAILURE; HEART MUSCLE CELL; HEART VENTRICLE HYPERTROPHY; HUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; REVIEW; SIGNAL TRANSDUCTION;

CARDIOMEGALY; HYPERTENSION; MICE; MODELS, BIOLOGICAL; MYOCARDIUM; PROTEIN STRUCTURE, TERTIARY; RECEPTORS, ADRENERGIC, ALPHA-1; RECEPTORS, G-PROTEIN-COUPLED; SIGNAL TRANSDUCTION;

EID: 33645507074     PISSN: 00219738     EISSN: 15588238     Source Type: Journal    
DOI: 10.1172/JCI28234     Document Type: Review

References (18)

1. Dorn, G.W., and Force, T. 2005. Protein kinase cascades in the regulation of cardiac hypertrophy. J. Clin. Invest. 115:527-537. doi:10.1172/JCI200524178.
2. Dorn, G.W. 2005. Physiologic growth and pathologic genes in cardiac development and cardiomyopathy. Trends Cardiovasc. Med. 15:185-189.
3. D'Angelo, D.D., et al. 1997. Transgenic Gαq overexpression induces cardiac contractile failure in mice. Proc. Natl. Acad. Sci. U. S. A. 94:8121-8126.
4. Sakata, Y., Hoit, B.D., Liggett, S.B., Walsh, R.A., and Dorn, G.W., II. 1998. Decompensation of pressure-overload hypertrophy in Gαq- overexpressing mice. Circulation. 97:1488-1495.
5. Akhter, S.A., et al. 1998. Targeting the receptor-Gq interface to inhibit in vivo pressure overload myocardial hypertrophy. Science. 280:574-577.
6. Milano, C.A., et al. 1994. Myocardial expression of a constitutively active alpha 1B-adrenergic receptor in transgenic mice induces cardiac hypertrophy. Proc. Natl. Acad. Sci. U. S. A. 91:10109-10113.
7. Hein, L., et al. 1997. Overexpression of angiotensin AT1 receptor transgene in the mouse myocardium produces a lethal phenotype associated with myocyte hyperplasia and heart block. Proc. Natl. Acad. Sci. U. S. A. 94:6391-6396.
8. 1-Adrenergic receptors prevent a maladaptive cardiac response to pressure overload. J. Clin. Invest. 116:1005-1015. doi:10.1172/JCI22811.
9. ALLHAT Collaborative Research Group. 2000. Major cardiovascular events in hypertensive patients randomized to doxazosin vs chlorthalidone. JAMA. 283:1967-1975.
10. Bryson, C.L., et al. 2004. Risk of congestive heart failure in an elderly population treated with peripheral alpha-1 antagonists. J. Am. Geriatr. Soc. 52:1648-1654.
11. Syed, F., et al. 2004. Physiological growth synergizes with pathological genes in experimental cardiomyopathy. Circ. Res. 95:1200-1206.
12. Offermanns, S., et al. 1998. Embryonic cardiomyocyte hypoplasia and craniofacial defects in G alpha q/G alpha 11-mutant mice. EMBO J. 17:4304-4312.
13. Wettschureck, N., et al. 2001. Absence of pressure overload induced myocardial hypertrophy after conditional inactivation of Galphaq/Galpha11 in cardiomyocytes. Nat. Med. 7:1236-1240.
14. O'Connell, T.D., et al. 2003. The α(1A/C)- and α(1B)- adrenergic receptors are required for physiological cardiac hypertrophy in the double-knockout mouse. J. Clin. Invest. 111:1783-1791. doi:10.1172/JCI200316100.
15. Garg, R., and Yusuf, S. 1995. Overview of randomized trials of angiotensin-converting enzyme inhibitors on mortality and morbidity in patients with heart failure. Collaborative Group on ACE Inhibitor Trials. JAMA. 273:1450-1456.
16. Sharma, D., Buyse, M., Pitt, B., and Rucinska, E.J. 2000. Meta-analysis of observed mortality data from all-controlled, double-blind, multiple-dose studies of losartan in heart failure. Losartan Heart Failure Mortality Meta-analysis Study Group. Am. J. Cardiol. 85:187-192.
17. del Carmen Medina, L., Vazquez-Prado, J., and Garcia-Sainz, J.A. 2000. Cross-talk between receptors with intrinsic tyrosine kinase activity and α1b-adrenoceptors. Biochem. J. 350:413-419.
18. Olivares-Reyes, J.A., et al. 2005. Agonist-induced interactions between angiotensin AT1 and epidermal growth factor receptors. Mol. Pharmacol. 68:356-364.